Patrick Henry Beusker

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Syntarga Bv, Synthon Biopharmaceuticals B.v., Byondis B.v.. Active years: 2007-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Henry Beusker. Retrieved from https://idiyas.com/inventor/patrick-henry-beusker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 64.3

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 251(Granted Patents)

Company Filing History:

Synthon Biopharmaceuticals B.v.

Years Active: 2007-2022

Loading Chart...

Areas of Expertise:

Duocarmycin

Antibody Drug Conjugates

CC-1065 Analogs

Bifunctional Linkers

In Vivo Antitumor Activity

Prodrugs

Self-Elimination-Release

Water-Soluble

Conjugates

Triazole-Containing

Spacers

Multiple Self-Elimination

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11382982 - Duocarmycin ADCs showing improved in vivo antitumor activity (2022-07-12),

2. 11052155 - Conjugates of CC-1065 analogs and bifunctional linkers (2021-07-06),

3. 10603387 - Duocarmycin ADCs showing improved in vivo antitumor activity (2020-03-31),

4. 9901567 - Substituted CC-1065 analogs and their conjugates (2018-02-27),

5. 9890159 - Process for making duocarmycin prodrugs (2018-02-13),

6. 9815784 - CC-1065 analogs and their conjugates (2017-11-14),

7. 9629924 - Conjugates of CC-1065 analogs and bifunctional linkers (2017-04-25),

8. 9421278 - Duocarmycin ADCS showing improved in vivo antitumor activity (2016-08-23),

9. 8940784 - Water-soluble CC-1065 analogs and their conjugates (2015-01-27),

10. 8889868 - CC-1065 analogs and their conjugates (2014-11-18),

11. 8680293 - Substituted CC-1065 analogs and their conjugates (2014-03-25),

12. 8158590 - Triazole-containing releasable linkers, conjugates thereof, and methods of preparation (2012-04-17),

13. 7705045 - Prodrugs built as multiple self-elimination-release spacers (2010-04-27),

14. 7223837 - Elongated and multiple spacers in activatible prodrugs (2007-05-29),

Title: Trailblazing Inventor: Patrick Henry Beusker

Introduction:

Patrick Henry Beusker is a visionary inventor based in Nijmegen, NL, who has made significant contributions to the field of medical technology. With an impressive portfolio of 14 patents, Beusker is a trailblazer in creating innovative solutions to combat various diseases, particularly cancer.

Latest Patents:

1. Duocarmycin ADCs showing improved in vivo antitumor activity: Beusker's invention focuses on duocarmycin-containing antibody-drug conjugates (ADCs) tailored for treating human solid tumors and haematological malignancies expressing HER2. This innovation holds promise for the treatment of breast cancer, gastric cancer, bladder cancer, and other forms of cancer.

2. Conjugates of CC-1065 analogs and bifunctional linkers: Beusker's invention introduces novel analogs of the DNA-alkylating agent CC-1065 and their conjugates. These conjugates are designed to deliver and release DNA-alkylating agents selectively, offering a potential treatment for various illnesses characterized by abnormal cell proliferation.

Career Highlights:

Throughout his career, Beusker has been associated with esteemed companies such as Syntarga B.V. and Synthon Biopharmaceuticals B.V., where he has driven innovation and pushed the boundaries of medical technology. His commitment to creating impactful solutions has earned him recognition in the field of biomedical research.

Collaborations:

Beusker has collaborated closely with accomplished professionals in the field, including Franciscus Marinus Hendrikus De Groot and Henri Johannes Spijker. These partnerships have been instrumental in advancing his research and bringing his inventions to fruition.

Conclusion:

Patrick Henry Beusker's unwavering dedication to innovation and his groundbreaking work in developing advanced medical technologies have positioned him as a pioneering figure in the world of inventions. His patents not only showcase his technical expertise but also reflect his profound impact on improving healthcare outcomes. Beusker's legacy continues to inspire and shape the landscape of medical innovation, setting a high standard for future inventors to follow.

Profile summary based on public USPTO records.